fig1
Figure 1. Schematic demonstrating the mechanism of action of BiTE & CAR-T. T-cell redirecting therapies targeting tumor-associated antigen of interest. mAB: Monoclonal antibody; scFv: single-chain variable fragment; TAA: tumor-associated antigen.
